Nijmegen
Netherlands
Radboud University Nijmegen - Radboud University Medical Center
HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial
HIV, adolescents, dolutegravir, short cycle therapy, young people, randomised controlled trial
cabotegravir, rilpivirine, plasma, light instability, ultra-high performance liquid chromatography, MS/MS detection
dolutegravir, bictegravir, raltegravir, doravirine, breastmilk, ultra-high performance liquid chromatography, MS/MS detection, HIV, mother-to-child transmission